Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Priority Review Voucher Program For Rare Pediatric Diseases Extended As FDA Lowers Fee

Sep 29 2016

• By Derrick Gingery

Priority Review Voucher

Related Content

Pediatric Rare Disease Voucher Program Faces Expiration

Sep 11 2016

FDA Wouldn't Get Funding Boost As Part Of Senate GOP Innovation Bill

Mar 10 2016

Review Voucher Program For Rare Pediatric Diseases Should Not Be Reauthorized, US FDA Says

Mar 03 2016

FDA Priority Review Costs Remain Stable While Voucher Fee Ticks Up

Sep 01 2014

Orphan Designation Requests To Get Slower Reviews

May 11 2016

Tracking The Priority Review Vouchers

Jul 27 2016

PDUFA Fees Forced Down For FY 2017 Due To Refund Provision

Jul 27 2016

Duchenne Surprise: Sarepta Prices Exondys 51 Below Expectations

Sep 20 2016

Related Companies

Sarepta Therapeutics, Inc.

Additional Topics

United States Review Pathway Drug Review Legislation Regulation BioPharmaceutical

More from Review Pathways

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window